ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ATHX Athersys Inc

0.1018
0.00 (0.00%)
Pre Market
Last Updated: 19:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Athersys Inc ATHX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.1018 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.1018
more quote information »

Recent News

Date Time Source Heading
1/08/202406:31EDGAR2Form 8-K - Current report
12/22/202316:09EDGAR2Form 8-K - Current report
12/21/202310:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202307:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/18/202307:00EDGAR2Form 8-K - Current report
10/16/202315:52BWAthersys Extends Near Term Liquidity with Proceeds from..
10/12/202308:28EDGAR2Form 8-K - Current report
10/11/202308:27EDGAR2Form 8-K - Current report
10/10/202307:30BWAthersys Reports Interim Analysis Results of MASTERS-2..
10/06/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/06/202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:41EDGAR2Form 8-K - Current report
10/03/202315:30BWAthersys Licenses its Animal Health Assets to Ardent Animal..
10/02/202316:05EDGAR2Form 8-K - Current report
10/02/202316:04BWAthersys Director Jane Wasman Appointed Board Chair
9/25/202315:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
9/21/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
9/19/202311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202320:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/18/202320:04EDGAR2Form 8-K - Current report
9/14/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202309:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/13/202316:13EDGAR2Form S-3 - Registration statement under Securities Act of..
9/11/202307:46EDGAR2Form 8-K - Current report
9/06/202313:45BWGrant Awarded to Newcastle University to Research Athersys’..
8/21/202313:36EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
8/18/202309:14EDGAR2Form 8-K - Current report
8/17/202320:30BWAthersys, Inc. Announces Pricing of $3.5 Million Public..
8/17/202315:15EDGAR2Form DEF 14A - Other definitive proxy statements
8/16/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/16/202316:01BWAthersys Reports Second Quarter 2023 Financial Results and..
8/11/202307:19EDGAR2Form 8-K - Current report
8/11/202307:00BWAthersys Appoints Neema Mayhugh, PhD to its Board of..
8/10/202316:03EDGAR2Form 8-K - Current report
8/08/202307:02EDGAR2Form 8-K - Current report
8/07/202316:02EDGAR2Form S-1/A - General form for registration of securities..
7/31/202312:38BWAthersys to Host Business Update Conference Call on August..
7/31/202307:01EDGAR2Form 8-K - Current report
7/26/202308:19EDGAR2Form S-1/A - General form for registration of securities..
7/14/202315:31EDGAR2Form S-1 - General form for registration of securities under..
7/14/202315:16EDGAR2Form 8-K/A - Current report: [Amend]
7/06/202308:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/06/202308:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202313:04EDGAR2Form 8-K - Current report
6/01/202315:40BWPatient Enrollment Begins in Third and Final Cohort of the..
5/23/202307:30BWAthersys Restructures Debt with Supplier
5/18/202308:58BWAthersys Reports First Quarter 2023 Financial Results and..
5/08/202308:49BWAthersys to Participate in Three Upcoming Conferences
5/01/202307:30BWAthersys to Participate in The Cellular Therapies and..

Your Recent History

Delayed Upgrade Clock